Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Roma
Clinical trial register · Italy

Clinical Trials in Roma, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Italy and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 6791 matching records held by the registry are in this view. Synced 11 Oct 2026, 03:19 UTC
6791
Studies in scope
all four open statuses
4079
Recruiting now
open to new participants
1019
Lead sponsors
across recruiting studies
Top sites
Milan 98 Roma 43 Rome 40 Naples 40 Rozzano 27
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Fondazione Policlinico Universitario Agostino Gemelli IRCCS197 AstraZeneca71 Novartis Pharmaceuticals52 Janssen Research & Development, LLC44 Merck Sharp & Dohme LLC43 Clear sponsor filter
Site location
Milan98 Roma43 Rome40 Naples40 Rozzano27
All 66 locations
Target enrolment
to

Trials with a site in Roma

43 of 6791 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Italy
Start
Recruiting
Merck Sharp & Dohme LLC
Phase 3
876
Bergamo, Milan, Florence, Perugia, Novara, Roma
2026-05-04
Recruiting
A Clinical Study of MK-1045 in People With Non-Hodgkin Lymphoma (MK-1045-008)
NCT07519772Lymphoma, Non-Hodgkin, Lymphoma, Follicular, Lymphoma, Large B-Cell, Diffuse
DrugMK-1045
Merck Sharp & Dohme LLC
Phase 1/2
280
Campania, Candiolo, Milan, Roma
2026-05-03
Recruiting
Merck Sharp & Dohme LLC
Phase 3
590
Rozzano, Orbassano, Verona, Arezzo, Genova, Milan, Roma
2026-04-23
Recruiting
Merck Sharp & Dohme LLC
Phase 3
400
Milan, Roma
2026-03-18
Recruiting
A Clinical Study of MK-1045 in People With Lupus or Rheumatoid Arthritis (MK-1045-004)
NCT07363590Systemic Lupus Erythematosus, Rheumatoid Arthritis
DrugMK-1045
Merck Sharp & Dohme LLC
Phase 1
21
Rozzano, Roma
2026-02-19
Recruiting
Merck Sharp & Dohme LLC
Phase 3
900
Brescia, Lecco, Milan, Padova, Roma, Torino
2026-02-16
Recruiting
Merck Sharp & Dohme LLC
Phase 1/2
170
Meldola, Milan, Roma
2026-01-29
Recruiting
Merck Sharp & Dohme LLC
Phase 3
1,023
Meldola, Aviano, Milan, Brescia, Catania, Padova, Roma, Torino
2026-01-19
Recruiting
Merck Sharp & Dohme LLC
Phase 2
180
Ravenna, Milan, Roma
2025-12-12
Recruiting
Merck Sharp & Dohme LLC
Phase 2
150
Rozzano, Milan, Roma
2025-12-04
Recruiting
Merck Sharp & Dohme LLC
Phase 3
1,000
Bergamo, Milan, Naples, Roma
2025-07-21
Recruiting
Merck Sharp & Dohme LLC
Phase 1/2
360
Orbassano, Brescia, Milan, Naples, Roma
2025-07-03
Active, closed
Merck Sharp & Dohme LLC
Phase 2
149
Ancona, Milan, Roma
2025-06-09
Recruiting
Merck Sharp & Dohme LLC
Phase 2
160
Milan, Naples, Padova, Roma
2025-05-29
Recruiting
Merck Sharp & Dohme LLC
Phase 2
144
Florence, Milan, Roma
2025-05-28
Recruiting
Merck Sharp & Dohme LLC
Phase 1/2
50
Milan, Roma, Torino
2025-05-26
Recruiting
Merck Sharp & Dohme LLC
Phase 3
1,123
Meldola, Milan, Catania, Florence, Naples, Pisa, Roma, Torino
2025-05-22
Recruiting
Merck Sharp & Dohme LLC
Phase 2
96
Milan, Florence, Roma
2025-05-13
Active, closed
Merck Sharp & Dohme LLC
Phase 2
130
Milan, Verona, Bologna, Genova, Pavia, Roma, Sassari
2025-05-12
Active, closed
Merck Sharp & Dohme LLC
Phase 2
440
Bergamo, Pavia, Roma
2025-04-16
Recruiting
Merck Sharp & Dohme LLC
Phase 3
770
Aviano, Milan, Pisa, Bari, Brescia, Naples, Padova, Roma
2025-04-09
Recruiting
Merck Sharp & Dohme LLC
Phase 2
90
Milan, Roma
2025-03-30
Active, closed
Merck Sharp & Dohme LLC
Phase 2
60
Florence, Milan, Roma
2025-03-20
Recruiting
Merck Sharp & Dohme LLC
Phase 3
1,000
Rome, Bologna, Genova, Milan, Novara, Padova, Roma
2025-03-16
Recruiting
A Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Cancer (V940-011/INTerpath-011)
NCT06833073Urinary Bladder Neoplasms, Non-Muscle Invasive Bladder Neoplasms, Carcinoma in Situ
DrugIntismeran autogene
Merck Sharp & Dohme LLC
Phase 2
308
Milan, Rome, Arezzo, Roma
2025-03-11
Active, closed
Merck Sharp & Dohme LLC
Phase 1/2
180
Milan, Roma
2024-11-03
Active, closed
Merck Sharp & Dohme LLC
Phase 3
300
Florence, Alessandria, Bologna, Milan, Pavia, Roma, Varese
2024-07-16
Recruiting
Merck Sharp & Dohme LLC
Phase 1/2
220
Milan, Roma
2024-06-20
Active, closed
Merck Sharp & Dohme LLC
Phase 3
550
Bari, Milan, Florence, Roma
2024-06-11
Recruiting
Merck Sharp & Dohme LLC
Phase 3
1,200
Meldola, Aviano, Milan, Rozzano, Bologna, Genova, Roma
2024-04-14
Recruiting
Merck Sharp & Dohme LLC
Phase 3
614
Bari, Meldola, Udine, Milan, Bergamo, Catanzaro, Florence, Roma
2023-12-15
Active, closed
A Study of Zilovertamab Vedotin (MK-2140) as Monotherapy and in Combination in Participants With Aggressive and Indolent B-cell Malignancies (MK-2140-006)
NCT05458297Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Follicular Lymphoma, Richter Transformation Lymphoma
DrugsZilovertamab vedotin·Nemtabrutinib
Merck Sharp & Dohme LLC
Phase 2
189
Bologna, Rozzano, Alessandria, Roma
2022-07-21
Recruiting
Merck Sharp & Dohme LLC
Phase 2/3
290
Rozzano, Bologna, Naples, Roma
2022-01-14
Recruiting
Efficacy and Safety of Nemtabrutinib (MK-1026) in Participants With Hematologic Malignancies (MK-1026-003)
NCT04728893Hematologic Malignancies, Waldenstroms Macroglobulinaemia, Non-Hodgkins Lymphoma, Chronic Lymphocytic Leukaemia
DrugNemtabrutinib
Merck Sharp & Dohme LLC
Phase 2
490
Bari, Bologna, Brescia, Milan, Naples, Pavia, Reggio Emilia, Roma
2021-04-05
Active, closed
Merck Sharp & Dohme LLC
Phase 3
747
Meldola, Rozzano, Orbassano, Arezzo, Bari, Milan, Pavia, Roma
2021-02-25
Active, closed
Merck Sharp & Dohme LLC
Phase 3
990
Roma, Rome, Milan, Candiolo, Brescia, Naples, Padova
2021-01-10
Active, closed
Merck Sharp & Dohme LLC
Phase 3
672
Modena, Florence, Verona, Brescia, Milan, Padova, Roma
2020-12-08
Active, closed
Merck Sharp & Dohme LLC
Phase 3
6,033
Rome, Padova, Bari, Catania, Roma
2020-02-27
Recruiting
Merck Sharp & Dohme LLC
Phase 1/2
450
Florence, Milan, Roma
2019-12-19
Recruiting
Merck Sharp & Dohme LLC
Observational
1,065
Florence, Milan, Roma
2019-12-19
Active, closed
Merck Sharp & Dohme LLC
Phase 3
595
Roma, Orbassano, Vicenza, Arezzo, Catania, Milan, Naples, Pavia
2019-07-24
Active, closed
Merck Sharp & Dohme LLC
Phase 3
976
Meldola, Bari, Bergamo, Genova, Milan, Naples, Padova, Roma
2018-09-12
Active, closed
Merck Sharp & Dohme LLC
Phase 2
340
Roma, Aviano, Naples, Torino
2018-04-09
Rows per page Showing 1–43 of 43
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with an Italian investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 11 October 2026. https://priyalifescience.com/clinical-trials-italy/city/roma

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Italy and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 6,791 studies in total at the last sync on 11 Oct 2026, 03:19 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 43 of those studies with a site in Roma that also match the filters currently applied.

How many clinical trials are recruiting in Roma?

28 of the 43 studies on this page are recruiting new participants as of the 11 Oct 2026, 03:19 UTC sync. A further 0 have not yet opened recruitment, 15 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Roma), 43 studies
PhaseStudiesRecruitingShare
Phase 3191144.2%
Phase 214832.6%
Phase 1/27616.3%
Observational112.3%
Phase 1112.3%
Phase 2/3112.3%

Most active sponsors

Lead sponsors with the most studies (Roma)
Lead sponsorStudiesRecruiting
Merck Sharp & Dohme LLC4328
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.